BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20830537)

  • 21. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Yang Z; Shi W; Zhu B; Hu S; Zhang Y; Wang M; Zhang J; Yao Z; Zhang Y
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):327-33. PubMed ID: 23092835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
    Bertagna F; Treglia G; Piccardo A; Giubbini R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm.
    Nilsson IL; Arnberg F; Zedenius J; Sundin A
    World J Surg; 2011 Dec; 35(12):2691-7. PubMed ID: 21989645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal Thyroid Incidentalomas on
    de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
    Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
    Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
    Kwak JY; Kim EK; Yun M; Cho A; Kim MJ; Son EJ; Oh KK
    AJR Am J Roentgenol; 2008 Aug; 191(2):598-603. PubMed ID: 18647938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
    Kim H; Kim SJ; Kim IJ; Kim K
    Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
    Kim BH; Kim SJ; Kim K; Kim H; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
    Ann Nucl Med; 2015 Oct; 29(8):721-9. PubMed ID: 26108700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N; Dallaire J; Vallée É; Belzile M
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules.
    Kim SJ; Kim BH; Jeon YK; Kim SS; Kim IJ
    Ann Nucl Med; 2011 Jun; 25(5):347-53. PubMed ID: 21271313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
    Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
    PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
    Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
    Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
    Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
    Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
    Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
    Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
    Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.